Health ❯Pharmaceuticals ❯Weight Loss

GLP-1 Drugs

Wegovy Consumer Behavior Ozempic Orforglipron Social Impact Consumer Impact Obesity Treatment

Guidelines Tie Diet and Exercise to GLP-1 Drug Success as India Launches Treatments

JAMA Internal Medicine’s new protocol focuses on protein-rich meals with resistance training to sustain GLP-1–driven weight loss

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Weight Loss Drugs Reshape Food Industry and Consumer Habits

GLP-1 Drugs Show Promise Beyond Diabetes and Obesity but Raise Cost and Ethical Concerns

Elon Musk and RFK Jr. Clash Over Weight-Loss Drug Policies

Cost and Efficacy Concerns Arise for GLP-1 Weight Loss Drugs